TrialAssure, a prominent pharmaceutical technology provider dedicated to advancing clinical trial disclosure and transparency, has introduced TrialAssure ANONYMIZE® 3.0, its latest iteration of data and document anonymization software. This flagship product incorporates machine learning (ML), natural language processing (NLP), and artificial intelligence (AI) to ensure the protection of patient and company confidential information while facilitating data sharing within the pharmaceutical industry and beyond.
Key Features of ANONYMIZE 3.0:
Enhanced User Experience: ANONYMIZE 3.0 offers a modernized design and intuitive navigation for improved usability.
Centralized Workbench: Users benefit from a comprehensive view of all projects and tasks in one location, enhancing efficiency.
Updated Rule Structure: Streamlined decision-making processes for anonymization tasks ensure efficiency and practicality.
Extended Document Support: ANONYMIZE 3.0 now supports additional document types, including Microsoft Office documents and emails, alongside pre-existing PDF functionality.
Improved Risk Score Visualization: Enhanced visualization tools track progress in mitigating re-identification risks, providing users with greater insights.
Industry Impact and Future Direction:
Zach Weingarden, Director of Product Solutions at TrialAssure, emphasizes the transformative potential of ANONYMIZE 3.0, highlighting its blend of AI advancements and industry expertise. As regulatory focus on anonymization intensifies, TrialAssure aims to equip pharmaceutical companies, vendors, and technology partners with the necessary tools to navigate evolving requirements effectively.
Expanded Scope Beyond Pharma:
Recognizing the broader need for anonymization solutions, TrialAssure integrates ANONYMIZE 3.0 updates into its TRUSANO.AI platform. This expansion enables users outside the pharmaceutical industry, including government, finance, and legal sectors, to leverage state-of-the-art anonymization technology for protecting commercially confidential information (CCI) and personal data.
Time and Cost Savings:
Users of ANONYMIZE and TRUSANO.AI report significant time savings of up to 80 percent compared to manual methods, underscoring the efficiency gains facilitated by TrialAssure’s innovative solutions.
Request a Demo:
Interested parties can request a demo of TrialAssure ANONYMIZE 3.0 and TRUSANO.AI via the official TrialAssure website.
About TrialAssure:
TrialAssure is a globally recognized data transparency company offering intelligent software and service solutions for the pharmaceutical industry and beyond. Leveraging AI and ML technologies, TrialAssure’s Ultimate Transparency Suite® facilitates compliance with data transparency requirements, including anonymization, compliance tracking, and content development. With a proven track record and commitment to innovation, TrialAssure continues to lead in the evolving landscape of data transparency.